Myocardial ischemia is a medical condition characterized by reduced blood flow to the heart muscle, usually due to the obstruction or narrowing of coronary arteries. This restriction in blood supply deprives the heart muscle of oxygen and vital nutrients, leading to potential damage or cell death. The most common cause of myocardial ischemia is atherosclerosis, where the arteries become narrowed by the buildup of fatty deposits, cholesterol, and other substances. The condition can manifest with symptoms such as chest pain or discomfort, known as angina, and in severe cases, it can result in a heart attack. Timely diagnosis and intervention are crucial to managing myocardial ischemia and preventing further complications, emphasizing the importance of lifestyle modifications, medication, and, in some cases, surgical interventions to restore blood flow and preserve heart function.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India